Human Adrenomedullin Up-regulates Interleukin-13 Receptor α2 Chain in Prostate CancerIn vitroandIn vivo: A Novel Approach to Sensitize Prostate Cancer to Anticancer Therapy
Authors:
Open Access
- 14 November 2008
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (22) , 9311-9317
Abstract
Interleukin-13 (IL-13) receptor α2 (IL-13Rα2), a high-affinity IL-13 binding subunit and a tumor antigen, is amplified in a variety of human tumor cell lines and tumors in vivo. By cDNA microarray, we have shown that gene transfer of human and rat adrenomedullin (AM) up-regulates IL-13Rα2 in a human prostate tumor cell line. Here, we show that IL-13Rα2 mRNA and protein are also up-regulated in PC-3 prostate tumor cells by recombinant AM (rAM) and human synthetic AM peptide in a dose-dependent manner in vitro and in vivo in mouse prostate tumor model. The 8- to 10-fold up-regulation of IL-13Rα2 by rAM or AM peptide in prostate tumor cells in vitro and in vivo increased their sensitivity to IL-13PE cytotoxin consisting of IL-13 and a truncated form of Pseudomonas exotoxin. Immunodeficient mice with established prostate tumors transfected with AM or treated with AM peptide showed reduction in tumor size by intratumoral administration of IL-13PE in a dose-dependent manner. At the highest dose (three 100 μg/kg/d every alternate day), >70% reduction of tumor size was observed compared with controls (P ≤ 0.01). These results indicate that two completely unrelated hormones (AM and IL-13) are closely related to each other and that we have identified a novel role of AM in sensitizing certain types of prostate tumors to IL-13R–directed therapeutic agent. [Cancer Res 2008;68(22):9311–7]Keywords
All Related Versions
This publication has 41 references indexed in Scilit:
- Characterization of a Novel Human Tumor Antigen Interleukin-13 Receptor α2 ChainCancer Research, 2006
- Gene expression profiling identifies IL‐13 receptor α2 chain as a therapeutic target in prostate tumor cells overexpressing adrenomedullinInternational Journal of Cancer, 2004
- Potent antitumor activity of IL-13 cytotoxin in human pancreatic tumors engineered to express IL-13 receptor α2 chain in vivoGene Therapy, 2003
- Gene transfer of interleukin 13 receptor α2 chain dramatically enhances the antitumor effect of IL-13 receptor–targeted cytotoxin in human prostate cancer xenograftsCancer Gene Therapy, 2001
- Sensitization of Cancer Cells to Interleukin 13- Pseudomonas Exotoxin-Induced Cell Death by Gene Transfer of Interleukin 13 Receptor α ChainHuman Gene Therapy, 2000
- Adrenomedullin, a Multifunctional Regulatory PeptideEndocrine Reviews, 2000
- Structure of IL-13 Receptor: Analysis of Subunit Composition in Cancer and Immune CellsBiochemical and Biophysical Research Communications, 1997
- Interleukin-13 Receptors on Human Prostate Carcinoma Cell Lines Represent a Novel Target for a Chimeric Protein Composed of IL-13 and a Mutated Form of Pseudomonas ExotoxinJournal of Urology, 1997
- Receptor for Interleukin (IL) 13 Does Not Interact with IL4 but Receptor for IL4 Interacts with IL13 on Human Glioma CellsJournal of Biological Chemistry, 1996
- Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human PheochromocytomaBiochemical and Biophysical Research Communications, 1993